Singapore markets open in 5 hours 18 minutes
Straits Times Index
3,253.79 -3.03 (-0.09%) S&P 500
4,305.40 +8.26 (+0.19%) Dow
34,150.58 +238.14 (+0.70%) Nasdaq
13,104.66 -23.40 (-0.18%) BTC-USD
23,926.53 -155.75 (-0.65%) CMC Crypto 200
568.15 -3.76 (-0.66%)
Gilead Sciences, Inc. (GILD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:42PM EDT. Market open.
| Previous close | 66.21 |
| Open | 66.16 |
| Bid | 66.16 x 800 |
| Ask | 66.16 x 900 |
| Day's range | 65.65 - 66.42 |
| 52-week range | 57.17 - 74.12 |
| Volume | |
| Avg. volume | 7,001,598 |
| Market cap | 82.979B |
| Beta (5Y monthly) | 0.35 |
| PE ratio (TTM) | 20.24 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.92 (4.41%) |
| Ex-dividend date | 14 Sept 2022 |
| 1y target est | N/A |
- Editor's pickYahoo Finance Video
Nasdaq 100 surges ahead of this week's retail earnings
Yahoo Finance's Jared Blikre takes a look at how the Nasdaq 100 and major sectors are performing into the close.
- Zacks
Gilead (GILD) Announces Positive Data on Breast Cancer Drug
Gilead (GILD) breast cancer drug Trodelvy improves overall survival in pre-treated HR+/HER2- metastatic breast cancer patients. The company will also acquire the remaining rights to the drug.
- Motley Fool
Why Gilead Sciences Stock Was a 5% Winner Today
Gilead Sciences (NASDAQ: GILD) stock was off to a good start this week, rising by more than 5% on Monday against the modest (0.4%) gain of the S&P 500 index. The prominent pharmaceutical company had some good news to impart about an important cancer drug. Gilead announced that morning that its breast cancer treatment Trodelvy recorded "statistically significant and clinically meaningful" results in a phase 3 clinical trial.
© 2022 Yahoo. All rights reserved.
